
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation
Cédric Peleman, Sven Francque, Tom Vanden Berghe
EBioMedicine (2024) Vol. 102, pp. 105088-105088
Open Access | Times Cited: 15
Cédric Peleman, Sven Francque, Tom Vanden Berghe
EBioMedicine (2024) Vol. 102, pp. 105088-105088
Open Access | Times Cited: 15
Showing 15 citing articles:
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Seogsong Jeong, Yun Hwan Oh, Joseph Ahn, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 487-499
Open Access | Times Cited: 9
Seogsong Jeong, Yun Hwan Oh, Joseph Ahn, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 487-499
Open Access | Times Cited: 9
Shanshan Wang, Zankai Wu, Xueshan Bu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 5
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders
Yuqi He, Yumeng Lin, Jinfeng Song, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Yuqi He, Yumeng Lin, Jinfeng Song, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies
Izabela Berdowska, M. Matusiewicz, Izabela Fecka
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2394-2394
Open Access
Izabela Berdowska, M. Matusiewicz, Izabela Fecka
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2394-2394
Open Access
Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway
Guangjie Shu, Ke Chen, Junyan Li, et al.
Phytomedicine (2024) Vol. 134, pp. 155989-155989
Closed Access | Times Cited: 3
Guangjie Shu, Ke Chen, Junyan Li, et al.
Phytomedicine (2024) Vol. 134, pp. 155989-155989
Closed Access | Times Cited: 3
Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials
Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105998-105998
Closed Access | Times Cited: 2
Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105998-105998
Closed Access | Times Cited: 2
Ironing out MAFLD: Therapeutic targeting of liver ferroptosis
Tuo Shao, Raymond T Chung
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2167-2169
Closed Access | Times Cited: 2
Tuo Shao, Raymond T Chung
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2167-2169
Closed Access | Times Cited: 2
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Santiago Iturbe-Rey, Cláudia Maccali, Marco Arrese, et al.
Atherosclerosis (2024) Vol. 400, pp. 119053-119053
Open Access | Times Cited: 1
Santiago Iturbe-Rey, Cláudia Maccali, Marco Arrese, et al.
Atherosclerosis (2024) Vol. 400, pp. 119053-119053
Open Access | Times Cited: 1
Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy
Yiming Zhang, Jing Li, Jiane Liu, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
Yiming Zhang, Jing Li, Jiane Liu, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
Mechanisms of Vitamins Inhibiting Ferroptosis
Meng Zhang, Xin Chen, Yumei Zhang
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1571-1571
Open Access | Times Cited: 1
Meng Zhang, Xin Chen, Yumei Zhang
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1571-1571
Open Access | Times Cited: 1
MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation
Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 1
Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 1
SILAC-Based Characterization of Plasma-Derived Extracellular Vesicles in Patients Undergoing Partial Hepatectomy
Ulrike Resch, Hubert Hackl, David Pereyra, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10685-10685
Open Access
Ulrike Resch, Hubert Hackl, David Pereyra, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10685-10685
Open Access
Magnesium Supplementation Modifies Arthritis Synovial and Splenic Transcriptomic Signatures Including Ferroptosis and Cell Senescence Biological Pathways
Teresina Laragione, Carolyn Harris, Pércío S. Gulko
Nutrients (2024) Vol. 16, Iss. 23, pp. 4247-4247
Open Access
Teresina Laragione, Carolyn Harris, Pércío S. Gulko
Nutrients (2024) Vol. 16, Iss. 23, pp. 4247-4247
Open Access
Histopathology of MASLD: Insights into Liver Tissue Changes
Sven Francque, Ann Driessen
(2024), pp. 61-85
Closed Access
Sven Francque, Ann Driessen
(2024), pp. 61-85
Closed Access